L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.
Background: Cachexia, a >10% loss of body-weight, is one factor determining the poor prognosis of pancreatic cancer. Deficiency of L-Carnitine has been proposed to cause cancer cachexia.Findings: We screened 152 and enrolled 72 patients suffering from advanced pancreatic cancer in a prospective, mul...
| Publicado en: | Nutrition Journal Vol. 11; pp. 52 - 53 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | research randomized controlled trial Journal Article |
| Publicado: |
BioMed Central
2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |